Sofosbuvir

Details

Files

Generic Name:

Sofosbuvir

Project Status:

Complete

Therapeutic Area:

Hepatitis C, chronic

Manufacturer:

Gilead Sciences Canada Inc.

Call for patient/clinician input open:

October 1, 2013

Brand Name:

Sovaldi

Project Line:

Reimbursement Review

Project Number:

SR0356-000

Call for patient/clinician input closed:

October 23, 2013

NOC Status at Filing:

Pre NOC

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Hepatitis C, chronic

Recommendation Type:

List with criteria/condition

Final Recommendation:

August 18, 2014

Files

Submission Status Report View PDF

Clinical Report View PDF

Pharmacoeconomic Report View PDF

Recommendation and Reasons View PDF

Last Updated : October 1, 2013